PROVIDENCE – The Emma Pendleton Bradley Hospital, Memorial Hospital of Rhode Island and the South County Hospital Healthcare System have been named Top Performers on Key Quality Measures by The Joint Commission, the leading accreditor of U.S. health care organizations.
The distinction of Top Performer on Key Quality Measures is awarded to hospitals with proven excellence in accountability-measure performance. This year, the distinction was awarded to the top 33 percent of all Joint Commission-accredited hospitals reporting performance data for 2012, according the report released Wednesday.
Of the three Rhode Island hospitals receiving recognition, Pawtucket-based Memorial Hospital earned the most distinctions for its accountability-measure performance in the areas of heart attack treatment, heart failure treatment, pneumonia treatment and surgical care.
“We understand that what matters most to patients here at Memorial is safe, effective care,” said Edward Schottland, acting president of Memorial, which recently joined the Care New England health care system, in a release. “That is why we have made a commitment to accreditation and to positive patient outcomes through evidence-based processes. The distinction of being a Joint Commission Top Performer on Key Quality Measures demonstrates that we are seeing success.”
Bradley Hospital, located in East Providence and part of the Lifespan health care system, received distinction for its hospital-based inpatient psychiatric treatment, while the independent South County Hospital in South Kingstown earned recognition for its heart attack treatment, pneumonia treatment and surgical care.
Each hospital named as a Joint Commission “Top Performer on Key Quality Measures” must achieve cumulative performance of 95 percent or better across all reported accountability measures, in addition to other measures of performance, the report said.
“Memorial Hospital and all the Top Performer hospitals have demonstrated an exceptional commitment to quality improvement and they should be proud of their achievement,” said Dr. Mark R. Chassin, president and CEO of The Joint Commission.
